Cargando…

Zellweger spectrum disorders: clinical overview and management approach

Zellweger spectrum disorders (ZSDs) represent the major subgroup within the peroxisomal biogenesis disorders caused by defects in PEX genes. The Zellweger spectrum is a clinical and biochemical continuum which can roughly be divided into three clinical phenotypes. Patients can present in the neonata...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klouwer, Femke C. C., Berendse, Kevin, Ferdinandusse, Sacha, Wanders, Ronald J. A., Engelen, Marc, Poll-The, Bwee Tien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666198/ https://www.ncbi.nlm.nih.gov/pubmed/26627182 http://dx.doi.org/10.1186/s13023-015-0368-9

Ejemplares similares

Cholic acid therapy in Zellweger spectrum disorders
por: Berendse, Kevin, et al.
Publicado: (2016)

Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
por: Berendse, Kevin, et al.
Publicado: (2015)

Reply: Low bone mineral density is a common feature of Zellweger spectrum disorders
por: Klouwer, Femke C.C., et al.
Publicado: (2016)

Coagulopathy in Zellweger spectrum disorders: a role for vitamin K
por: Zeynelabidin, Sara, et al.
Publicado: (2017)

High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders
por: Berendse, Kevin, et al.
Publicado: (2014)

Hyperinsulinism in a patient with a Zellweger Spectrum Disorder and a 16p11.2 deletion syndrome
por: Hoytema van Konijnenburg, Eva M.M., et al.
Publicado: (2020)

Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report
por: Blomqvist, Maria, et al.
Publicado: (2017)

Arginine improves peroxisome functioning in cells from patients with a mild peroxisome biogenesis disorder
por: Berendse, Kevin, et al.
Publicado: (2013)

Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants
por: Lipiński, Patryk, et al.
Publicado: (2019)

Cholbam® and Zellweger spectrum disorders: treatment implementation and management
por: Anderson, Janaina Nogueira, et al.
Publicado: (2021)

Peroxisomal abnormalities in the immortalized human hepatocyte (IHH) cell line
por: Klouwer, Femke C. C., et al.
Publicado: (2016)

Autophagy Inhibitors Do Not Restore Peroxisomal Functions in Cells With the Most Common Peroxisome Biogenesis Defect
por: Klouwer, Femke C. C., et al.
Publicado: (2021)

Long-Term Cholic Acid Therapy in Zellweger Spectrum Disorders
por: Heubi, James E., et al.
Publicado: (2018)

X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
por: Engelen, Marc, et al.
Publicado: (2012)

Renal oxalate stones in children with Zellweger spectrum disorders
por: Alhazmi, Hamdan Hammad
Publicado: (2018)

Acute Late-Onset Cirrhosis in Zellweger Spectrum Disorder
por: Hsu, Mark, et al.
Publicado: (2023)

A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders
por: Mast, Fred D., et al.
Publicado: (2011)

Abnormal activation of MAPKs pathways and inhibition of autophagy in a group of patients with Zellweger spectrum disorders and X-linked adrenoleukodystrophy
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

An Infant with Blended Phenotype of Zellweger Spectrum Disorder and Congenital Muscular Dystrophy
por: Gupta, Priyanka, et al.
Publicado: (2021)

Long-Term Cholic Acid Treatment in a Patient with Zellweger Spectrum Disorder
por: Heubi, James E., et al.
Publicado: (2018)

Emotional experience in parents of children with Zellweger spectrum disorders: A qualitative study
por: Bose, Mousumi, et al.
Publicado: (2019)

Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders
por: Heubi, James E., et al.
Publicado: (2017)

Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)

Reply: Low bone mineral density is a common feature of Zellweger spectrum disorders
por: Rush, Eric T., et al.
Publicado: (2016)

A novel PEX1 mutation in a Moroccan family with Zellweger spectrum disorders
por: Bousfiha, Amale, et al.
Publicado: (2017)

Genotype–phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders
por: Borgia, Paola, et al.
Publicado: (2022)

The important role of biochemical and functional studies in the diagnostics of peroxisomal disorders
por: Ferdinandusse, Sacha, et al.
Publicado: (2016)

Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools
por: Vasiljevic, Eva, et al.
Publicado: (2019)

Metabolic Interplay between Peroxisomes and Other Subcellular Organelles Including Mitochondria and the Endoplasmic Reticulum
por: Wanders, Ronald J. A., et al.
Publicado: (2016)

Mitochondrial Fatty Acid Oxidation Disorders: Laboratory Diagnosis, Pathogenesis, and the Complicated Route to Treatment
por: Wanders, Ronald J.A., et al.
Publicado: (2020)

Neonate with classic Zellweger syndrome
por: Kashgari, Amna
Publicado: (2019)

A newly identified mutation in the PEX26 gene is associated with a milder form of Zellweger spectrum disorder
por: Tanaka, Akemi J., et al.
Publicado: (2019)

Zellweger spectrum disorder: A cross-sectional study of symptom prevalence using input from family caregivers
por: Bose, Mousumi, et al.
Publicado: (2020)

Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene
por: Sevin, Caroline, et al.
Publicado: (2011)

Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
por: Engelen, Marc, et al.
Publicado: (2012)

A novel mutation in the PEX26 gene in a family from Dagestan with members affected by Zellweger spectrum disorder
por: Semenova, Natalia A., et al.
Publicado: (2021)

Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review
por: Bose, Mousumi, et al.
Publicado: (2022)

Insufficiency of ciliary cholesterol in hereditary Zellweger syndrome
por: Miyamoto, Tatsuo, et al.
Publicado: (2020)

Allogeneic Hematopoietic Stem Cell Transplantation for PEX1-Related Zellweger Spectrum Disorder: A Case Report and Literature Review
por: Chen, Kai, et al.
Publicado: (2021)

Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities
por: Wang, Xiao-Ming, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1akstne2omrbb8q6qje4ld8qb9